Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus (Q43493342)

24 November 2017

title

Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus (English)

1 reference

24 November 2017

vaccinia virus

1 reference

J Foloppe

1

1 reference

24 November 2017

J Kintz

2

1 reference

24 November 2017

N Futin

3

1 reference

24 November 2017

A Findeli

4

1 reference

24 November 2017

P Cordier

5

1 reference

24 November 2017

Y Schlesinger

6

1 reference

24 November 2017

C Hoffmann

7

1 reference

24 November 2017

C Tosch

8

1 reference

24 November 2017

J-M Balloul

9

1 reference

24 November 2017

P Erbs

10

1 reference

24 November 2017

publication date

15 May 2008

1 reference

24 November 2017

1 reference

24 November 2017

volume

15

1 reference

24 November 2017

issue

20

1 reference

24 November 2017

page(s)

1361-1371

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2008.82

24 November 2017

exact match

0 references

cites work

Surgical therapy for metastatic disease to the liver

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Molecular therapies for colorectal cancer metastatic to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Modified vaccinia virus Ankara as a vector for suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Cytolytic viruses as potential anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Replicating viruses as selective cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Conditionally replicating herpes vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Applications of pox virus vectors to vaccination: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

7 January 2021

Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

7 January 2021

Inhibition of liver metastases in nude mice by the combined action of 5-fluorouracil and interferon.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.82

7 January 2021

Identifiers

DOI

10.1038/GT.2008.82

1 reference

Dimensions Publication ID

24 November 2017

1029969429

0 references

1 reference